Sign in or Register   Sign in or Register
  |  

Rat Anti-IFNG Recombinant Antibody (XMG1.2) (CBMAB-1024-LY)

This product is rat antibody recognizes mouse IFNγ. The antibody XMG1.2 immunoassay techniques such as: Neutralization, ELISpot.
See all IFNG antibodies
Published Data

Summary

Host Animal
Rat
Specificity
Mouse
Clone
XMG1.2
Antibody Isotype
IgG1
Application
Neutralization, ELISpot

Basic Information

Specificity
Mouse
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Interferon Gamma
Introduction
Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons.
Entrez Gene ID
UniProt ID
Function
Type II interferon produced by immune cells such as T-cells and NK cells that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation (PubMed:16914093, PubMed:8666937).

Primarily signals through the JAK-STAT pathway after interaction with its receptor IFNGR1 to affect gene regulation (PubMed:8349687).

Upon IFNG binding, IFNGR1 intracellular domain opens out to allow association of downstream signaling components JAK2, JAK1 and STAT1, leading to STAT1 activation, nuclear translocation and transcription of IFNG-regulated genes. Many of the induced genes are transcription factors such as IRF1 that are able to further drive regulation of a next wave of transcription (PubMed:16914093).

Plays a role in class I antigen presentation pathway by inducing a replacement of catalytic proteasome subunits with immunoproteasome subunits (PubMed:8666937).

In turn, increases the quantity, quality, and repertoire of peptides for class I MHC loading (PubMed:8163024).

Increases the efficiency of peptide generation also by inducing the expression of activator PA28 that associates with the proteasome and alters its proteolytic cleavage preference (PubMed:11112687).

Up-regulates as well MHC II complexes on the cell surface by promoting expression of several key molecules such as cathepsins B/CTSB, H/CTSH, and L/CTSL (PubMed:7729559).

Participates in the regulation of hematopoietic stem cells during development and under homeostatic conditions by affecting their development, quiescence, and differentiation (By similarity).
Biological Process
Adaptive immune response Source: GO_Central
Apoptotic process Source: MGI
Astrocyte activation Source: ARUK-UCL
Cell surface receptor signaling pathway Source: ProtInc
Defense response to virus Source: UniProtKB-KW
Extrinsic apoptotic signaling pathway Source: BHF-UCL
Humoral immune response Source: GO_Central
Interferon-gamma-mediated signaling pathway Source: CAFA
Macrophage activation involved in immune response Source: ARUK-UCL
Macrophage differentiation Source: ARUK-UCL
Microglial cell activation Source: ARUK-UCL
Negative regulation of amyloid-beta clearance Source: ARUK-UCL
Negative regulation of epithelial cell differentiation Source: BHF-UCL
Negative regulation of gene expression Source: UniProtKB
Negative regulation of interleukin-17 production Source: BHF-UCL
Negative regulation of smooth muscle cell proliferation Source: BHF-UCL
Negative regulation of tau-protein kinase activity Source: ARUK-UCL
Negative regulation of transcription, DNA-templated Source: CAFA
Negative regulation of transcription by RNA polymerase II Source: BHF-UCL
Neuroinflammatory response Source: ARUK-UCL
Positive regulation of amyloid-beta formation Source: ARUK-UCL
Positive regulation of autophagy Source: UniProtKB
Positive regulation of calcidiol 1-monooxygenase activity Source: BHF-UCL
Positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response Source: UniProtKB
Positive regulation of cell population proliferation Source: BHF-UCL
Positive regulation of cellular respiration Source: ARUK-UCL
Positive regulation of chemokine production Source: ARUK-UCL
Positive regulation of core promoter binding Source: CAFA
Positive regulation of cytokine production Source: ARUK-UCL
Positive regulation of epithelial cell migration Source: CACAO
Positive regulation of exosomal secretion Source: UniProtKB
Positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity Source: BHF-UCL
Positive regulation of fructose 1,6-bisphosphate metabolic process Source: BHF-UCL
Positive regulation of gene expression Source: UniProtKB
Positive regulation of glycolytic process Source: ARUK-UCL
Positive regulation of inflammatory response Source: ARUK-UCL
Positive regulation of interleukin-12 production Source: UniProtKB
Positive regulation of interleukin-1 beta production Source: ARUK-UCL
Positive regulation of interleukin-23 production Source: BHF-UCL
Positive regulation of interleukin-6 production Source: ARUK-UCL
Positive regulation of iron ion import across plasma membrane Source: ARUK-UCL
Positive regulation of killing of cells of other organism Source: BHF-UCL
Positive regulation of membrane protein ectodomain proteolysis Source: BHF-UCL
Positive regulation of MHC class II biosynthetic process Source: ARUK-UCL
Positive regulation of neurogenesis Source: ARUK-UCL
Positive regulation of neuron death Source: ARUK-UCL
Positive regulation of nitric oxide biosynthetic process Source: BHF-UCL
Positive regulation of nitric-oxide synthase biosynthetic process Source: ARUK-UCL
Positive regulation of nitrogen compound metabolic process Source: ARUK-UCL
Positive regulation of NMDA glutamate receptor activity Source: ARUK-UCL
Positive regulation of osteoclast differentiation Source: BHF-UCL
Positive regulation of peptidyl-serine phosphorylation of STAT protein Source: MGI
Positive regulation of phagocytosis Source: ARUK-UCL
Positive regulation of protein-containing complex assembly Source: CAFA
Positive regulation of protein deacetylation Source: CAFA
Positive regulation of protein import into nucleus Source: CAFA
Positive regulation of protein localization to plasma membrane Source: UniProtKB
Positive regulation of protein phosphorylation Source: CAFA
Positive regulation of protein serine/threonine kinase activity Source: CAFA
Positive regulation of signaling receptor activity Source: ARUK-UCL
Positive regulation of smooth muscle cell apoptotic process Source: BHF-UCL
Positive regulation of tumor necrosis factor (ligand) superfamily member 11 production Source: BHF-UCL
Positive regulation of tumor necrosis factor production Source: ARUK-UCL
Positive regulation of tyrosine phosphorylation of STAT protein Source: BHF-UCL
Positive regulation of vitamin D biosynthetic process Source: BHF-UCL
Receptor signaling pathway via JAK-STAT Source: ARUK-UCL
Regulation of growth Source: UniProtKB-KW
Regulation of insulin secretion Source: BHF-UCL
Regulation of protein ADP-ribosylation Source: CAFA
Response to virus Source: MGI
Cellular Location
Secreted
Involvement in disease
Aplastic anemia (AA):
A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. It is characterized by peripheral pancytopenia and marrow hypoplasia.
Immunodeficiency 69 (IMD69):
A form of Mendelian susceptibility to mycobacterial disease, a rare condition caused by impairment of interferon-gamma mediated immunity. It is characterized by predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine, environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections. Clinical outcome severity depends on the degree of impairment of interferon-gamma mediated immunity. IMD69 is an autosomal recessive disorder manifesting with fever, hepatosplenomegaly, leukocytosis, and thrombocytosis during the acute infection.
PTM
Proteolytic processing produces C-terminal heterogeneity, with proteins ending alternatively at Gly-150, Met-157 or Gly-161.

Petermann, F., Pękowska, A., Johnson, C. A., Jankovic, D., Shih, H. Y., Jiang, K., ... & O’Shea, J. J. (2019). The magnitude of IFN-γ responses is fine-tuned by DNA architecture and the non-coding transcript of Ifng-as1. Molecular cell, 75(6), 1229-1242.

Thiem, A., Hesbacher, S., Kneitz, H., di Primio, T., Heppt, M. V., Hermanns, H. M., ... & Schrama, D. (2019). IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression. Journal of Experimental & Clinical Cancer Research, 38(1), 1-15.

Stein, N., Berhani, O., Schmiedel, D., Duev-Cohen, A., Seidel, E., Kol, I., ... & Mandelboim, O. (2019). IFNG-AS1 enhances interferon gamma production in human natural killer cells. Iscience, 11, 466-473.

Zaidi, M. R. (2019). The interferon-gamma paradox in cancer. Journal of Interferon & Cytokine Research, 39(1), 30-38.

Pereiro, P., Figueras, A., & Novoa, B. (2019). Insights into teleost interferon-gamma biology: An update. Fish & Shellfish Immunology, 90, 150-164.

Kang, S., Brown, H. M., & Hwang, S. (2018). Direct antiviral mechanisms of interferon-gamma. Immune network, 18(5).

Singh, N., Kansal, P., Ahmad, Z., Baid, N., Kushwaha, H., Khatri, N., & Kumar, A. (2018). Antimycobacterial effect of IFNG (interferon gamma)-induced autophagy depends on HMOX1 (heme oxygenase 1)-mediated increase in intracellular calcium levels and modulation of PPP3/calcineurin-TFEB (transcription factor EB) axis. Autophagy, 14(6), 972-991.

Karachaliou, N., Gonzalez-Cao, M., Crespo, G., Drozdowskyj, A., Aldeguer, E., Gimenez-Capitan, A., ... & Rosell, R. (2018). Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients. Therapeutic advances in medical oncology, 10, 1758834017749748.

Kimura, A., Ishida, Y., Furuta, M., Nosaka, M., Kuninaka, Y., Taruya, A., ... & Kondo, T. (2018). Protective roles of interferon‐γ in cardiac hypertrophy induced by sustained pressure overload. Journal of the American Heart Association, 7(6), e008145.

Chetchotisakd, P., Anunnatsiri, S., Nanagara, R., Nithichanon, A., & Lertmemongkolchai, G. (2018). Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated Mycobacterium abscessus infection. Journal of Immunology Research, 2018.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Rat Anti-IFNG Recombinant Antibody (XMG1.2)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare